The content is available as a PDF (265.2 KB).
editorial . 2020 Nov 18:ciaa1755. doi: 10.1093/cid/ciaa1755
SARS-CoV-2 Antibody Testing: Important but Imperfect
Jack T Stapleton
✉
Jack T Stapleton, M.D
Find articles by Jack T Stapleton
✉
Corrresponding author: Jack T. Stapleton, M.D. Iowa City Veterans Affairs Healthcare System and Professor, Departments of Internal Medicine, Microbiology and Immunology, The University of Iowa, 200 Hawkins Drive, UIHC, Iowa City, IA 52242, 319-356-3168, jack-stapleton@uiowa.edu
Received 2020 Nov 9.
Keywords: SARS-COV-2, COVID-19, prevalence, antibody testing
Published by Oxford University Press for the Infectious Diseases Society of America 2020. This work is written by (a) US Government employee(s) and is in the public domain in the US.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
This work is written by (a) US Government employee(s) and is in the public domain in the US.
PMCID: PMC7717217 PMID: 33206173
See commentary "Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons", ciaa1685.